A scandal flares up in the world around the British-Swedish vaccine. Previously, it was considered one of the most promising. Oxford University took an active part in its development. From the very beginning, the British-Swedish drug was the leader in the number of orders - 70 countries signed contracts with the company. Now more and more news appears either about a fatal outcome after using the drug, or about problems with blood circulation - blood clots appear among the recipients.
